Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-075214
Filing Date
2025-08-07
Accepted
2025-08-07 16:28:29
Documents
14
Effectiveness Date
2025-08-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2522704d1_s8.htm S-8 34549
2 EXHIBIT 5.1 tm2522704d1_ex5-1.htm EX-5.1 48130
3 EXHIBIT 23.2 tm2522704d1_ex23-2.htm EX-23.2 2004
4 EX-FILING FEES tm2522704d1_ex-filingfees.htm   iXBRL EX-FILING FEES 16362
  Complete submission text file 0001104659-25-075214.txt   221501

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2522704d1_ex-filingfees_htm.xml XML 4960
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289369 | Film No.: 251194601
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)